Why did Nvidia resume AI chip sales to China?
How are Trump's tariffs impacting US inflation?
What caused Starbucks to end remote work policy?
Why did JPMorgan CEO defend Fed chair Powell?
How will Apple's rare earth deal affect supply chains?
What stalled the US House crypto legislation vote?
Why is Tesla's India market debut so expensive?
GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults
benzinga.com/news/fda/25/07/46423319/gsk-seeks-fda-nod-to-broaden-rsv-vaccine-for-younger-at-risk-adults
On Monday, the U.S. Food and Drug Administration (FDA) agreed to review GSK plc’s (NYSE:GSK) application to extend the indication of Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 18-49 who are at increased risk.
GSK's RSV vaccine is approved in the U.S. to…
This story appeared on benzinga.com, 2025-07-15 16:06:38.